Celltrion HealthCare Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion HealthCare Co Ltd with three other
companies in this sector in South Korea:
sales of 982.07 billion Korean Won [US$827.89 million]
of which 88%
was Bio Business Division),
Samsung Biologics Co Ltd
(535.81 billion Korean Won [US$451.68 million]
of which 99%
was Antibody Drugs), and
Medy Tox Inc
(205.44 billion Korean Won [US$173.19 million]
of which 95%
was Finished Goods).